FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Glenmark Pharmaceuticals Clotrimazole and Betamethasone Dipropionate Recall

Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0

Glenmark Pharmaceuticals Inc., USA · Mahwah, NJ

Risk level
Class III
Reported by FDA
Aug 21, 2019
Recall ID
D-1743-2019
Check your lot numberHow we source this data

Summary

Glenmark Pharmaceuticals recalled Clotrimazole and Betamethasone Dipropionate starting Aug 7, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1743-2019 on Aug 21, 2019. Reason: Temperature Abuse: Complaints received of liquidy texture. Status: Terminated.

Why it was recalled

Temperature Abuse: Complaints received of liquidy texture.

Product description

Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Village: Kishanpura, Baddi Nalagarth Road, District: Solan, Himachal Pradesh-173205, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-298-17

Lot numbers, UPCs & expiration codes

Lot #: 05180734, Exp. 03/2020

Where it was sold

Nationwide with the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1743-2019
Classification
Class III
Status
Terminated
Recall initiated
Aug 7, 2019
FDA report date
Aug 21, 2019
Quantity
31,224 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Glenmark Pharmaceuticals Inc., USA

Original FDA data

Every field from FDA enforcement report D-1743-2019, exactly as published.

Show all FDA fields
City
Mahwah
State
NJ
Status
Terminated
Country
United States
Event ID
83526
Address
750 Corporate Dr
Code information
Lot #: 05180734, Exp. 03/2020
Postal code
07430-2009
Report date
Aug 21, 2019
Product type
Drugs
Recall number
D-1743-2019
Classification
Class III
Recalling firm
Glenmark Pharmaceuticals Inc., USA
Product quantity
31,224 tubes
Termination date
Nov 9, 2020
Reason for recall
Temperature Abuse: Complaints received of liquidy texture.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Village: Kishanpura, Baddi Nalagarth Road, District: Solan, Himachal Pradesh-173205, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-298-17
Distribution pattern
Nationwide with the United States
Recall initiation date
Aug 7, 2019
Initial firm notification
Letter
Center classification date
Aug 15, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1743-2019, published Aug 21, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls